Clinical Trial Update: Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease [NA]

View source ↗

Summary

This clinical trial update shows that REGEnLIFE SAS is recruiting participants to evaluate the efficacy of RGn600 in mild-to-moderate Alzheimer's disease; no re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• RGn600

Snippet

Sponsor: REGEnLIFE SAS | Conditions: Alzheimer Disease | NA | Status: RECRUITING